Literature DB >> 26614307

Rasch Analysis of the General Self-Efficacy Scale in Workers with Traumatic Limb Injuries.

Tzu-Yi Wu1, Wan-Hui Yu1, Chien-Yu Huang1, Wen-Hsuan Hou2,3,4, Ching-Lin Hsieh5,6.   

Abstract

Purpose The purpose of this study was to apply Rasch analysis to examine the unidimensionality and reliability of the General Self-Efficacy Scale (GSE) in workers with traumatic limb injuries. Furthermore, if the items of the GSE fitted the Rasch model's assumptions, we transformed the raw sum ordinal scores of the GSE into Rasch interval scores. Methods A total of 1076 participants completed the GSE at 1 month post injury. Rasch analysis was used to examine the unidimensionality and person reliability of the GSE. The unidimensionality of the GSE was verified by determining whether the items fit the Rasch model's assumptions: (1) item fit indices: infit and outfit mean square (MNSQ) ranged from 0.6 to 1.4; and (2) the eigenvalue of the first factor extracted from principal component analysis (PCA) for residuals was <2. Person reliability was calculated. Results The unidimensionality of the 10-item GSE was supported in terms of good item fit statistics (infit and outfit MNSQ ranging from 0.92 to 1.32) and acceptable eigenvalues (1.6) of the first factor of the PCA, with person reliability = 0.89. Consequently, the raw sum scores of the GSE were transformed into Rasch scores. Conclusions The results indicated that the items of GSE are unidimensional and have acceptable person reliability in workers with traumatic limb injuries. Additionally, the raw sum scores of the GSE can be transformed into Rasch interval scores for prospective users to quantify workers' levels of self-efficacy and to conduct further statistical analyses.

Entities:  

Keywords:  Rasch analysis; Self-efficacy; Traumatic limb injury; Unidimensionality

Mesh:

Year:  2016        PMID: 26614307     DOI: 10.1007/s10926-015-9617-y

Source DB:  PubMed          Journal:  J Occup Rehabil        ISSN: 1053-0487


  22 in total

1.  Optimizing rating scale category effectiveness.

Authors:  John M Linacre
Journal:  J Appl Meas       Date:  2002

Review 2.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

3.  Past and present issues in Rasch analysis: the functional independence measure (FIM™) revisited.

Authors:  Åsa Lundgren Nilsson; Alan Tennant
Journal:  J Rehabil Med       Date:  2011-10       Impact factor: 2.912

4.  Validating, improving reliability, and estimating correlation of the four subscales in the WHOQOL-BREF using multidimensional Rasch analysis.

Authors:  Wen-Chung Wang; Grace Yao; Yih-Jian Tsai; Jung-Der Wang; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

Review 5.  The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?

Authors:  Alan Tennant; Philip G Conaghan
Journal:  Arthritis Rheum       Date:  2007-12-15

6.  On the Theory of Scales of Measurement.

Authors:  S S Stevens
Journal:  Science       Date:  1946-06-07       Impact factor: 47.728

7.  Rasch analysis of the General Self-Efficacy Scale in spinal cord injury.

Authors:  Claudio Peter; Alarcos Cieza; Szilvia Geyh
Journal:  J Health Psychol       Date:  2013-03-05

8.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

9.  Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals.

Authors:  W C Holmes; J A Shea
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

10.  Validation of the Chinese general self-efficacy scale among individuals with schizophrenia in Hong Kong.

Authors:  Frank P F Chiu; Hector W H Tsang
Journal:  Int J Rehabil Res       Date:  2004-06       Impact factor: 1.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.